Westmount Partners, LLC

Position in JNJ — Johnson & Johnson

CIK 2051491 LOS ANGELES, CA

Position in JNJ

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$2,472,143

-$293,695 QoQ

Shares Held

9,734

-14.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.82%

of 13F equity value

Holder Rank

#2,168

of 4,664 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 89% Shared 0% None 11%

Healthcare · as of Jun 30, 2026

Westmount Partners, LLC holds $10,104,775 across 9 Drug Manufacturers - General names. JNJ ranks #2 (24.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,289	$2,745,495
2	JNJ	Johnson & Johnson This page	9,734	$2,472,143
3	ABBV	AbbVie Inc.	5,727	$1,441,142
4	AMGN	Amgen Inc	3,735	$1,352,518
5	MRK	Merck & Co., Inc.	5,013	$644,170
6	BMY	Bristol Myers Squibb Co	10,185	$586,859
7	GILD	Gilead Sciences, Inc.	2,887	$364,743
8	PFE	Pfizer Inc	10,594	$255,103

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,472,143	9,734	-14.0%	Shares	Sole	2026-07-07
2026-03-31	$2,765,838	11,315	+12.7%	Shares	Sole	2026-04-16
2025-12-31	$2,078,398	10,043	+1.3%	Shares	Sole	2026-01-15
2025-09-30	$1,838,253	9,914	-22.6%	Shares	Sole	2025-10-14
2025-06-30	$1,955,811	12,804	-2.6%	Shares	Sole	2025-07-09
2025-03-31	$2,179,635	13,143	-5.8%	Shares	Sole	2025-05-01
2024-12-31	$2,018,461	13,957	-2.0%	Shares	Sole	2025-01-13
2024-09-30	$2,308,382	14,244	-0.2%	Shares	Sole	2025-01-13
2024-06-30	$2,085,264	14,267	+2.0%	Shares	Sole	2025-01-28
2024-03-31	$2,213,236	13,991	-2.5%	Shares	Sole	2025-01-28
2023-12-31	$2,250,159	14,356	+0.6%	Shares	Sole	2025-01-28
2023-09-30	$2,223,487	14,276	+6.5%	Shares	Sole	2025-01-28
2023-06-30	$2,218,961	13,406	+1.0%	Shares	Sole	2025-01-28
2023-03-31	$2,057,160	13,272	+1.1%	Shares	Sole	2025-01-29
2022-12-31	$2,318,884	13,127	—	Shares	Sole	2025-01-28
No filing history on record for this holder in this stock.